1.2 GW TOPCon Plant in Surat Tests Whether ALMM Rules Can Pull New Money In

A firm with no prior energy-sector footprint is now betting on India's solar cell manufacturing gap, evidence of how far the ALMM List-II mandate has reshaped who wants in.

StarlinePS Enterprises, a company that entered the renewable energy business only in 2025 after building its history in diamond and jewellery trading, has invested ₹160 crore (roughly $17 million) in Celloraa Energy to establish a 1.2 GW Domestic Content Requirement (DCR)-compliant N-Type TOPCon solar cell manufacturing facility in Surat, Gujarat.

A Capacity Gap the Market Is Now Chasing

India's module manufacturing capacity has scaled well ahead of its cell manufacturing base for years, a mismatch the ALMM List-II mandate, requiring both ALMM-listed modules and ALMM-listed cells from June 2026, was designed to correct. India's cumulative ALMM-listed cell capacity stood at roughly 30 GW by May 2026, having added 2,829 MW since the prior month's update, according to Mercom India's tracking. Total 2025 additions reached nearly 119 GW of module capacity against just over 9 GW of cell capacity, the scale of the gap this and similar investments are now targeting.

Who Is Actually Entering This Market

What makes this deal notable is the entrant, not the size. StarlinePS has no prior track record in solar manufacturing or project development; its stated pivot into renewables, spanning solar, wind, hydro, and biomass, dates only to 2025. That a firm with this profile is now capitalising a TOPCon cell facility indicates the DCR-compliance demand floor created by ALMM List-II is drawing in capital that has no organic connection to the energy sector, purely on the strength of a guaranteed domestic buyer base.

So What This Signals, and What It Doesn't

At 1.2 GW, this is a modest addition against India's roughly 30 GW cell base, and $17 million is a small capital commitment relative to the capital intensity typical of cell manufacturing at scale. The signal value is directional rather than material: it suggests non-specialist capital sees the DCR mandate as durable enough to underwrite a multi-year manufacturing bet, which is itself informative about how the market is pricing policy risk on ALMM List-II. It does not, on its own, meaningfully close India's cell capacity gap.

Both companies' public statements, from StarlinePS director Shwet Koradiya and Celloraa Energy director Brijesh Gondaliya, use standard partnership-announcement language about confidence and vision, with no operational detail on production timelines, technology licensing, or commissioning dates.

What to Watch

• Whether Celloraa Energy discloses a construction timeline or commissioning date, currently absent from all public statements
• Whether StarlinePS makes further renewable-sector investments, which would confirm this as a genuine strategic pivot rather than a one-off capital deployment
• Whether similar non-specialist capital continues entering solar cell manufacturing as ALMM List-II enforcement tightens through 2026 and 2027